Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Chronic Liver Failure

ribavirin has been researched along with Chronic Liver Failure in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's26 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bassiony, MAA; Hanafy, AS; Hussein, S; Mohamed, MS1
Agarwal, K; Barnabas, A1
Kang, W; Lu, Y; Sun, Y; Tong, HI1
Amiri, M; Bailly, F; Funingana, G; Gonçalves, F; Hartig-Lavie, K; Maynard, M; Pradat, P; Virlogeux, V; Zoulim, F1
Chapman, R; Costella, A; De Angelis, D; Griffiths, J; Harris, HE; Harris, RJ; Ramsay, M; Thomas, B1
Andruszkiewicz, A; Bartoszewicz, K; Duczkowska, M; Jurczyk, K; Karpińska, E; Laurans, Ł; Parczewski, M; Socha, Ł; Sławiński, J; Wawrzynowicz-Syczewska, M; Zeair, S1
Aishima, S; Harimoto, N; Ikegami, T; Ito, S; Kawanaka, H; Maehara, Y; Ninomiya, M; Shirabe, K; Soejima, Y; Uchiyama, H; Wang, H; Yoshizumi, T1
Adams, L; Bowden, S; de Boer, B; Faddy, HM; Ma, MX; MacNicholas, R; MacQuillan, G; Nash, M; Speers, DJ1
Ahmad, J; Bach, N; Chang, C; Chernyiak, M; Doucette, JT; Fiel, MI; Florman, SS; Grewal, P; Khaitova, V; Kim-Schluger, L; Lim, KB; Liu, L; Odin, J; Perumalswami, P; Schiano, TD; Sima, HR1
Dusheiko, G; Kalafateli, M; Manousou, P1
Boccaccio, V; Bruno, S; Maisonneuve, P; Russo, ML1
Coilly, A; Duclos-Vallée, JC; Roche, B; Samuel, D1
Agarwal, R; Ahmad, J; Bach, N; Bansal, M; Bichoupan, K; Branch, A; Chang, C; Dieterich, D; Friedman, S; Gardenier, D; Grewal, P; Harty, A; Im, G; Khaitova, V; Kim-Schluger, L; Ku, L; Leong, J; Liu, L; Motamed, D; Ng, M; Odin, J; Patel, N; Perumalswami, P; Schiano, T; Yalamanchili, R1
Baños, I; Bellot, P; Bhamidimarri, KR; Brainard, DM; Campos-Varela, I; Castells, L; Grewal, P; Guaraldi, G; Hasson, H; McHutchison, JG; Morbey, A; Moreno, A; Terrault, NA1
Berg, T; Ferenci, P; Herzer, K; Hinrichsen, H; Inderson, A; Jimenez-Exposito, MJ; Klinker, H; Peck-Radosavljevic, M; Spengler, U; Welzel, TM; Zeuzem, S; Zhao, Y1
Albillos, A; Arenas, J; Badia, E; Baliellas, C; Blé, M; Buti, M; Calleja, JL; Carrión, JA; Castells, L; Crespo, J; de la Mata, M; Fernández Bermejo, M; Fernández Carrillo, C; Fernández, I; Fernández-Rodriguez, C; García-Samaniego, J; Granados, R; Herrero, JI; Lens, S; Llop, E; Mariño, Z; Moreno-Palomares, JJ; Moreno-Planas, JM; Pascasio, JM; Pons, C; Prieto, M; Romero, M; Salcedo, M; Salmerón, J; Turnes, J1
Castedal, M; Cederberg, S; Segenmark, M; Skoglund, C; Weiland, O1
Ikegami, T; Masuda, Y; Matsuda, K; Mita, A; Miwa, S; Miyagawa, S; Nakazawa, Y; Ohno, Y; Sano, K; Urata, K1
Dalton, H; Izopet, J; Kamar, N; Péron, JM1
Bzowej, N; Charlton, MR; Everson, GT; Nelson, DR; Prabhakar, A; Teng, LL; Terrault, NA1
Colombo, M1
Aikata, H; Chayama, K; Hiraga, N; Hiramatsu, A; Imamura, M; Kawakami, Y; Kawaoka, T; Miki, D; Ochi, H; Ohdan, H; Onoe, T; Takahashi, S; Takaki, S; Tashiro, H; Tsuge, M; Waki, K1
Al-Osaimi, AM; Brown, RS; Everhart, JE; Everson, GT; Gillespie, BW; Kulik, LM; Lok, AS; Rodrigo, del R; Saab, S; Shiffman, ML; Terrault, NA1
Acharya, SK; Goyal, R; Kumar, A; Panda, SK; Paul, SB1
Bahra, M; Boas-Knoop, S; Eurich, D; Kiessling, A; Neuhaus, P; Neuhaus, R; Neumann, UP; Puhl, G; Trautwein, C; Wasmuth, H; Yahyazadeh, A1
Coilly, A; Roche, B; Samuel, D1

Reviews

5 review(s) available for ribavirin and Chronic Liver Failure

ArticleYear
Treatment of chronic hepatitis C virus infection after liver transplantation.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Sep-30, Volume: 45 Suppl 5

    Topics: Antiviral Agents; Drug Interactions; End Stage Liver Disease; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Transplantation; Oligopeptides; Proline; Ribavirin; Secondary Prevention

2013
Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.
    Expert review of gastroenterology & hepatology, 2014, Volume: 8, Issue:3

    Topics: Anti-Retroviral Agents; Comorbidity; Disease Management; Disease Progression; End Stage Liver Disease; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2014
Is the benefit of treating patients with cirrhosis proven?
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36 Suppl 1

    Topics: Antiviral Agents; Drug Therapy, Combination; End Stage Liver Disease; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Ribavirin

2016
News and challenges in the treatment of hepatitis C in liver transplantation.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36 Suppl 1

    Topics: Antiviral Agents; Drug Therapy, Combination; End Stage Liver Disease; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Recurrence; Ribavirin

2016
Current management and perspectives for HCV recurrence after liver transplantation.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33 Suppl 1

    Topics: Antiviral Agents; Drug Therapy, Combination; End Stage Liver Disease; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Serine Proteinase Inhibitors; Time Factors; Treatment Outcome; Viral Load

2013

Trials

2 trial(s) available for ribavirin and Chronic Liver Failure

ArticleYear
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2011, Volume: 17, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Biopsy; End Stage Liver Disease; Female; Fibrosis; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome

2011
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.
    Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:5

    Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Preoperative Care; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome

2013

Other Studies

19 other study(ies) available for ribavirin and Chronic Liver Failure

ArticleYear
Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:12

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Carbamates; Drug Therapy, Combination; Egypt; End Stage Liver Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; International Normalized Ratio; Male; Middle Aged; Platelet Count; Prospective Studies; Pyrrolidines; Ribavirin; Serum Albumin; Severity of Illness Index; Sofosbuvir; Sustained Virologic Response; Valine

2017
Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:9

    Topics: Adult; Aged; Antiviral Agents; Drug-Related Side Effects and Adverse Reactions; End Stage Liver Disease; Female; Genotype; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Kidney; Kidney Function Tests; Male; Middle Aged; Oligopeptides; Proline; Prospective Studies; Ribavirin; Severity of Illness Index; Treatment Outcome; Viral Load

2014
Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios.
    Journal of hepatology, 2014, Volume: 61, Issue:3

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cost of Illness; End Stage Liver Disease; England; Health Care Costs; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Models, Statistical; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome

2014
Impact of antiviral treatment on survival in HCV-positive liver recipients.
    Annals of transplantation, 2014, Jul-30, Volume: 19

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; End Stage Liver Disease; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Poland; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Retrospective Studies; Ribavirin; Young Adult

2014
Different histological sequelae of immune-mediated graft dysfunction after interferon treatment in transplanted dual grafts from living donors.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014, Volume: 20, Issue:12

    Topics: Adult; Biopsy; End Stage Liver Disease; Female; Genetic Variation; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immune System; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Japan; Liver; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult

2014
Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient.
    The Medical journal of Australia, 2015, Mar-02, Volume: 202, Issue:4

    Topics: Antibodies, Viral; Antiviral Agents; Australia; End Stage Liver Disease; Follow-Up Studies; Hepatitis E; Hepatitis E virus; Humans; Liver Transplantation; Male; Middle Aged; Ribavirin; RNA, Viral; Transplant Recipients

2015
Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
    World journal of gastroenterology, 2015, May-28, Volume: 21, Issue:20

    Topics: Antiviral Agents; Biopsy; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Graft Survival; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interferons; Interleukins; Liver Transplantation; Male; Middle Aged; New York City; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Risk Factors; Time Factors; Treatment Outcome; Viral Load; Virus Activation

2015
Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplant.
    Journal of gastrointestinal and liver diseases : JGLD, 2015, Volume: 24, Issue:2

    Topics: Antiviral Agents; Biomarkers; Carbamates; Drug Therapy, Combination; End Stage Liver Disease; Hepatitis B virus; Hepatitis C; Humans; Imidazoles; Liver Transplantation; Male; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir; Time Factors; Treatment Outcome; Valine; Viral Load; Virus Activation

2015
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus.
    World journal of gastroenterology, 2016, Mar-07, Volume: 22, Issue:9

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepacivirus; Hepatitis C; Humans; Kaplan-Meier Estimate; Liver Failure; Liver Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Ribavirin; Risk Factors; Sofosbuvir; Time Factors; Treatment Outcome; Virus Activation

2016
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
    Alimentary pharmacology & therapeutics, 2016, Volume: 43, Issue:12

    Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Transplant Recipients; Treatment Outcome; Valine

2016
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease.
    Transplant international : official journal of the European Society for Organ Transplantation, 2017, Volume: 30, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Carbamates; Cohort Studies; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Sofosbuvir; Treatment Outcome; Valine

2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.
    Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cause of Death; Cohort Studies; Disease Progression; End Stage Liver Disease; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Function Tests; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Registries; Retrospective Studies; Ribavirin; Risk Assessment; Severity of Illness Index; Sofosbuvir; Spain; Survival Analysis; Treatment Outcome

2017
INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
    Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Sweden; Treatment Outcome; Valine

2017
Clinicopathological features of hepatitis C virus disease after living donor liver transplantation: relationship with in situ hybridisation data.
    Pathology, 2011, Volume: 43, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Biopsy; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Immunosuppressive Agents; In Situ Hybridization; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin

2011
Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?
    Journal of hepatology, 2011, Volume: 54, Issue:6

    Topics: Adult; Aged; Antiviral Agents; End Stage Liver Disease; Female; France; Genotype; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Ribavirin; United Kingdom

2011
Treatment with pegylated interferon (PegIFN) combined with ribavirin (Rbv) is the only option for preventing HCV-related end stage liver disease.
    Journal of viral hepatitis, 2012, Volume: 19 Suppl 1

    Topics: Drug Therapy, Combination; End Stage Liver Disease; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Polyethylene Glycols; Ribavirin

2012
Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:9

    Topics: Adult; Aged; Antiviral Agents; Chi-Square Distribution; Confidence Intervals; Donor Selection; End Stage Liver Disease; Female; Genetic Testing; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Transplantation; Logistic Models; Male; Middle Aged; Odds Ratio; Polyethylene Glycols; Polymorphism, Single Nucleotide; Predictive Value of Tests; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome

2012
Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
    Antiviral therapy, 2012, Volume: 17, Issue:6

    Topics: Adolescent; Antiviral Agents; End Stage Liver Disease; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Liver Failure, Acute; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome

2012
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
    Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:1

    Topics: Adipokines; Adult; Antiviral Agents; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lectins; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Sex Factors; Statistics, Nonparametric; Tacrolimus; Time Factors; Young Adult

2013